List of Levoxyl drug patents
Levoxyl is owned by King Pharms.
Levoxyl contains Levothyroxine Sodium.
Levoxyl has a total of 3 drug patents out of which 2 drug patents have expired.
Expired drug patents of Levoxyl are:
- US6555581
- US7067148
Levoxyl was authorised for market use on 25 May, 2001.
Levoxyl is available in tablet;oral dosage forms.
Levoxyl can be used as method of use of administering levothyroxine.
The generics of Levoxyl are possible to be released after 02 October, 2023.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6555581 | KING PHARMS | Levothyroxine compositions and methods |
Feb, 2022
(11 months ago) | |
| US7067148 | KING PHARMS | Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
Feb, 2022
(11 months ago) | |
| US7101569 | KING PHARMS | Methods of administering levothyroxine pharmaceutical compositions |
Oct, 2023
(8 months from now) | |
Drugs and Companies using LEVOTHYROXINE SODIUM ingredient
Market Authorisation Date: 25 May, 2001
Treatment: Method of use of administering levothyroxine
Dosage: TABLET;ORAL
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic